公开(公告)号：US11713350B2

公开(公告)日：2023-08-01

申请号：US16991192

申请日：2020-08-12

Applicant: Hefei University of Technology

Inventor： Jihong Han ,  Yajun Duan ,  Shuang Zhang ,  Xiaoxiao Yang ,  Yuanli Chen

IPC: C07K16/22 ,  A61P3/06 ,  A61P3/10 ,  A61K48/00 ,  C12N15/113

CPC classification number: C07K16/22 ,  A61K48/005 ,  A61P3/06 ,  A61P3/10 ,  C12N15/113 ,  C12N2310/11 ,  C12N2310/14

Abstract: The present invention relates to a medicine for treating disorders of glucose and/or lipid metabolism. This invention demonstrates a new therapeutic target for treatment of glucose and/or lipid metabolic disorders. The invention further provides a method of treating glucose and/or lipid metabolic disorders, administering to a subject comprising a Nogo-B inhibitor, thereby treating the glucose and/or lipid metabolic disorders.

公开(公告)号：US20210087262A1

公开(公告)日：2021-03-25

申请号：US16991192

申请日：2020-08-12

Applicant: Hefei University of Technology

Inventor： Jihong Han ,  Yajun Duan ,  Shuang Zhang ,  Xiaoxiao Yang ,  Yuanli Chen

IPC: C07K16/22 ,  A61K48/00 ,  C12N15/113 ,  A61P3/10 ,  A61P3/06

Abstract: The present invention relates to a medicine for treating disorders of glucose and/or lipid metabolism. This invention demonstrates a new therapeutic target for treatment of glucose and/or lipid metabolic disorders. The invention further provides a method of treating glucose and/or lipid metabolic disorders, administering to a subject comprising a Nogo-B inhibitor, thereby treating the glucose and/or lipid metabolic disorders.